Physician profile
Ruby E Kim
NPI 1972762730
$13,380.03
in general payments reported to CMS, 2019-2025
43 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what 76% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,568 · 2020: $1,591 · 2021: $2,286 · 2022: $2,129 · 2023: $1,726 · 2024: $1,880 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,805.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $1,464.17 | 2019-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,249.39 | 2019-2025 | Relistor, Trulance |
| Medtronic, INC. | $1,228.34 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Boston Scientific Corporation | $991.41 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbvie INC. | $958.01 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $685.12 | 2019-2025 | Xtampza |
| Scilex Pharmaceuticals INC. | $681.50 | 2021-2025 | Ztlido |
| Abbott Laboratories | $568.26 | 2019-2024 | Eterna, Proclaim |
| Teva Pharmaceuticals USA, INC. | $547.87 | 2019-2024 | Ajovy, Austedo Xr |
| Pfizer INC. | $535.57 | 2019-2025 | |
| Lundbeck LLC | $519.38 | 2022-2025 | Vyepti |
| Merz North America, INC. | $515.36 | 2019-2022 | |
| Lilly USA, LLC | $502.85 | 2019-2023 | Emgality, Reyvow |
| Horizon Therapeutics Plc | $385.56 | 2019-2022 | |
| Allergan, INC. | $366.23 | 2019-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruby Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.